Similarly, a significant difference in the expression patterns of Bcl-XL and Bcl-2 was observed by immunostaining of the tumour samples using anti-Bcl-XL and anti-Bcl-2 antibodies (Figure 2B). This evidence concerns the gene BCL2L1 and neoplasm.